BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'P2Y purinoceptor 13' and Ligand = 'BDBM359087'   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
P2Y purinoceptor 13


(Homo sapiens (Human))		BDBM359087
PNG
(US10220040, Compound IIb)
Show SMILES COc1ccc(CN2CCC(CC2)c2cc(O)nc(n2)N2CCCCC2)cc1O
Show InChI InChI=1S/C22H30N4O3/c1-29-20-6-5-16(13-19(20)27)15-25-11-7-17(8-12-25)18-14-21(28)24-22(23-18)26-9-3-2-4-10-26/h5-6,13-14,17,27H,2-4,7-12,15H2,1H3,(H,23,24,28)
UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 2.99E+5n/an/an/an/a



Cerenis Therapeutics Holding SA

US Patent


Assay Description
Compounds were assayed for their agonist activity on P2Y13 GPCR transfected cells using a Ca++ flux assay (associated to fluorescent dye detection) w...

US Patent US10220040 (2019)


BindingDB Entry DOI: 10.7270/Q20K2BVK
More data for this
Ligand-Target Pair